Legend Biotech Corp. (LEGN)
18.78
+0.22
(+1.16%)
USD |
NASDAQ |
Oct 05, 16:00
18.78
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Max Drawdown (5Y) : 78.24% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 78.24% |
| August 31, 2026 | 78.24% |
| July 31, 2026 | 78.24% |
| June 30, 2026 | 78.24% |
| May 31, 2026 | 78.24% |
| April 30, 2026 | 78.24% |
| March 31, 2026 | 78.24% |
| February 28, 2026 | 78.24% |
| January 31, 2026 | 77.12% |
| December 31, 2025 | 72.18% |
| November 30, 2025 | 64.51% |
| October 31, 2025 | 63.80% |
| September 30, 2025 | 63.80% |
| August 31, 2025 | 63.80% |
| July 31, 2025 | 63.80% |
| June 30, 2025 | 63.80% |
| May 31, 2025 | 63.80% |
| April 30, 2025 | 60.46% |
| March 31, 2025 | 58.92% |
| February 28, 2025 | 58.92% |
| January 31, 2025 | 58.92% |
| December 31, 2024 | 57.53% |
| November 30, 2024 | 51.08% |
| October 31, 2024 | 48.37% |
| September 30, 2024 | 48.37% |
| Date | Value |
|---|---|
| August 31, 2024 | 48.37% |
| July 31, 2024 | 48.37% |
| June 30, 2024 | 48.37% |
| May 31, 2024 | 48.37% |
| April 30, 2024 | 45.56% |
| March 31, 2024 | 45.56% |
| February 29, 2024 | 45.56% |
| January 31, 2024 | 45.56% |
| December 31, 2023 | 45.56% |
| November 30, 2023 | 45.56% |
| October 31, 2023 | 45.56% |
| September 30, 2023 | 45.56% |
| August 31, 2023 | 45.56% |
| July 31, 2023 | 45.56% |
| June 30, 2023 | 45.56% |
| May 31, 2023 | 45.56% |
| April 30, 2023 | 45.56% |
| March 31, 2023 | 45.56% |
| February 28, 2023 | 45.56% |
| January 31, 2023 | 45.56% |
| December 31, 2022 | 45.56% |
| November 30, 2022 | 45.56% |
| October 31, 2022 | 45.56% |
| September 30, 2022 | 45.56% |
| August 31, 2022 | 45.56% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Gilead Sciences, Inc. | 26.58% |
| Ionis Pharmaceuticals, Inc. | 70.27% |
| Johnson & Johnson | 18.44% |
| Arbutus Biopharma Corp. | 84.78% |
| Capricor Therapeutics, Inc. | 91.80% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.52 |
| Beta (5Y) | 0.5708 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.72% |
| Historical Sharpe Ratio (5Y) | -0.3802 |
| Historical Sortino (5Y) | -0.8187 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.29% |